HEADER TRANSFERASE 11-APR-22 7XHY TITLE CRYSTAL STRUCTURE OF MERTK KINASE DOMAIN WITH BMS794833 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE MER; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: PROTO-ONCOGENE C-MER,RECEPTOR TYROSINE KINASE MERTK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MERTK, MER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACTERIAL EXPRESSION VECTOR; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PETDUET KEYWDS ATP COMPETITIVE INHIBITOR MERTK-BMS794833 COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.H.KIM,B.I.LEE REVDAT 2 29-NOV-23 7XHY 1 REMARK REVDAT 1 30-NOV-22 7XHY 0 JRNL AUTH S.H.BAE,J.H.KIM,T.H.PARK,K.LEE,B.I.LEE,H.JANG JRNL TITL BMS794833 INHIBITS MACROPHAGE EFFEROCYTOSIS BY DIRECTLY JRNL TITL 2 BINDING TO MERTK AND INHIBITING ITS ACTIVITY. JRNL REF EXP.MOL.MED. V. 54 1450 2022 JRNL REFN ISSN 1226-3613 JRNL PMID 36056187 JRNL DOI 10.1038/S12276-022-00840-X REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 16477 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1648 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.7100 - 4.9500 0.99 1328 150 0.1906 0.2264 REMARK 3 2 4.9400 - 3.9300 0.98 1246 139 0.1707 0.1968 REMARK 3 3 3.9300 - 3.4300 1.00 1260 135 0.1918 0.2378 REMARK 3 4 3.4300 - 3.1200 1.00 1243 142 0.2198 0.2539 REMARK 3 5 3.1200 - 2.8900 1.00 1261 137 0.2314 0.2756 REMARK 3 6 2.8900 - 2.7200 1.00 1238 134 0.2433 0.3019 REMARK 3 7 2.7200 - 2.5900 1.00 1241 138 0.2314 0.2957 REMARK 3 8 2.5900 - 2.4700 1.00 1247 140 0.2345 0.3169 REMARK 3 9 2.4700 - 2.3800 1.00 1216 137 0.2563 0.3129 REMARK 3 10 2.3800 - 2.3000 1.00 1235 136 0.2536 0.3337 REMARK 3 11 2.3000 - 2.2300 0.99 1222 137 0.2513 0.3139 REMARK 3 12 2.2200 - 2.1600 0.89 1092 123 0.2494 0.3276 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.273 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.285 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2249 REMARK 3 ANGLE : 1.045 3038 REMARK 3 CHIRALITY : 0.059 336 REMARK 3 PLANARITY : 0.007 382 REMARK 3 DIHEDRAL : 21.736 297 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XHY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-APR-22. REMARK 100 THE DEPOSITION ID IS D_1300028847. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 - 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 11C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : M REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16509 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : 23.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.16 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.47800 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7AAX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN CONCENTRATION 25 MG/ML PROTEIN REMARK 280 STORAGE BUFFER: TRIS-HCL PH 8.0, 500 MM NACL, 1 MM TRIS(2- REMARK 280 CARBOXYETHYL)PHOSPHINE HYDROCHLORIDE (TCEP) MOTHER LIQUOR: 0.1 M REMARK 280 TRIS-HCL PH 8.5, 4.3 M NACL PROTEIN: RESERVOIR: APO-MICROSEED = REMARK 280 300: 300: 100 NL OR 400: 400: 100 NL CO-CRYSTALIZATION 2MM REMARK 280 COMPOUND PREINCUBATION: 2HOURS IN ICE CRYOPROTECTANT SOLUTION: REMARK 280 0.1 M TRIS-HCL PH 8.5, 2.5 M NACL, 20% DMSO, 10 MM COMPOUNDS, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.71750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.71750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.06350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.26650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.06350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.26650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.71750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.06350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.26650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 35.71750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.06350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 46.26650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1038 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 567 REMARK 465 GLY A 596 REMARK 465 GLU A 597 REMARK 465 LEU A 623 REMARK 465 ASP A 624 REMARK 465 ASN A 625 REMARK 465 SER A 626 REMARK 465 SER A 627 REMARK 465 SER A 745 REMARK 465 LYS A 746 REMARK 465 LYS A 747 REMARK 465 ILE A 748 REMARK 465 TYR A 749 REMARK 465 SER A 750 REMARK 465 GLY A 751 REMARK 465 ASP A 752 REMARK 465 TYR A 753 REMARK 465 TYR A 754 REMARK 465 ARG A 755 REMARK 465 GLN A 756 REMARK 465 GLY A 757 REMARK 465 ARG A 758 REMARK 465 ILE A 759 REMARK 465 ALA A 760 REMARK 465 LYS A 761 REMARK 465 MET A 762 REMARK 465 ASP A 863 REMARK 465 VAL A 864 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 578 CG CD OE1 OE2 REMARK 470 PHE A 598 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 662 CG CD OE1 NE2 REMARK 470 ASP A 774 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 621 -164.86 -128.41 REMARK 500 GLN A 662 13.56 -68.83 REMARK 500 ARG A 722 -8.03 79.12 REMARK 500 ASP A 723 44.42 -141.18 REMARK 500 ALA A 773 -75.02 -95.70 REMARK 500 ARG A 775 9.52 52.55 REMARK 500 REMARK 500 REMARK: NULL DBREF 7XHY A 571 864 UNP Q12866 MERTK_HUMAN 571 864 SEQADV 7XHY GLY A 567 UNP Q12866 EXPRESSION TAG SEQADV 7XHY SER A 568 UNP Q12866 EXPRESSION TAG SEQADV 7XHY HIS A 569 UNP Q12866 EXPRESSION TAG SEQADV 7XHY MET A 570 UNP Q12866 EXPRESSION TAG SEQADV 7XHY ARG A 591 UNP Q12866 LYS 591 ENGINEERED MUTATION SEQADV 7XHY ARG A 693 UNP Q12866 LYS 693 ENGINEERED MUTATION SEQADV 7XHY ARG A 702 UNP Q12866 LYS 702 ENGINEERED MUTATION SEQADV 7XHY ARG A 856 UNP Q12866 LYS 856 ENGINEERED MUTATION SEQRES 1 A 298 GLY SER HIS MET GLU GLU LEU GLN ASN LYS LEU GLU ASP SEQRES 2 A 298 VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY ARG ILE SEQRES 3 A 298 LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU GLY ASN SEQRES 4 A 298 LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL ALA VAL SEQRES 5 A 298 LYS THR MET LYS LEU ASP ASN SER SER GLN ARG GLU ILE SEQRES 6 A 298 GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS ASP PHE SEQRES 7 A 298 SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL CYS ILE SEQRES 8 A 298 GLU MET SER SER GLN GLY ILE PRO LYS PRO MET VAL ILE SEQRES 9 A 298 LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR TYR LEU SEQRES 10 A 298 LEU TYR SER ARG LEU GLU THR GLY PRO ARG HIS ILE PRO SEQRES 11 A 298 LEU GLN THR LEU LEU ARG PHE MET VAL ASP ILE ALA LEU SEQRES 12 A 298 GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU HIS ARG SEQRES 13 A 298 ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP ASP MET SEQRES 14 A 298 THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS LYS ILE SEQRES 15 A 298 TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE ALA LYS SEQRES 16 A 298 MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU ALA ASP SEQRES 17 A 298 ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA PHE GLY SEQRES 18 A 298 VAL THR MET TRP GLU ILE ALA THR ARG GLY MET THR PRO SEQRES 19 A 298 TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP TYR LEU SEQRES 20 A 298 LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP CYS LEU SEQRES 21 A 298 ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP ARG THR SEQRES 22 A 298 ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU ARG LEU SEQRES 23 A 298 GLN LEU GLU ARG LEU LEU GLU SER LEU PRO ASP VAL HET E0X A 901 33 HET CL A 902 1 HET CL A 903 1 HET CL A 904 1 HET CL A 905 1 HET DMS A 906 4 HETNAM E0X ~{N}-[4-(2-AZANYL-3-CHLORANYL-PYRIDIN-4-YL)OXY-3- HETNAM 2 E0X FLUORANYL-PHENYL]-5-(4-FLUOROPHENYL)-4-OXIDANYLIDENE- HETNAM 3 E0X 1~{H}-PYRIDINE-3-CARBOXAMIDE HETNAM CL CHLORIDE ION HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 E0X C23 H15 CL F2 N4 O3 FORMUL 3 CL 4(CL 1-) FORMUL 7 DMS C2 H6 O S FORMUL 8 HOH *40(H2 O) HELIX 1 AA1 SER A 568 ASP A 579 1 12 HELIX 2 AA2 ASP A 583 ASN A 585 5 3 HELIX 3 AA3 ARG A 629 PHE A 644 1 16 HELIX 4 AA4 ASP A 678 ARG A 687 1 10 HELIX 5 AA5 PRO A 696 ASN A 716 1 21 HELIX 6 AA6 ALA A 725 ARG A 727 5 3 HELIX 7 AA7 PRO A 763 ILE A 767 5 5 HELIX 8 AA8 ALA A 768 ASP A 774 1 7 HELIX 9 AA9 THR A 778 THR A 795 1 18 HELIX 10 AB1 GLN A 805 HIS A 807 5 3 HELIX 11 AB2 GLU A 808 HIS A 815 1 8 HELIX 12 AB3 LEU A 826 CYS A 836 1 11 HELIX 13 AB4 ASP A 840 ARG A 844 5 5 HELIX 14 AB5 THR A 846 LEU A 861 1 16 SHEET 1 AA1 5 LEU A 587 GLY A 594 0 SHEET 2 AA1 5 SER A 600 LYS A 607 -1 O VAL A 601 N LEU A 593 SHEET 3 AA1 5 SER A 613 THR A 620 -1 O VAL A 618 N MET A 602 SHEET 4 AA1 5 PRO A 665 PRO A 672 -1 O LEU A 671 N ALA A 617 SHEET 5 AA1 5 GLY A 654 MET A 659 -1 N GLU A 658 O LYS A 666 SHEET 1 AA2 2 CYS A 729 LEU A 731 0 SHEET 2 AA2 2 VAL A 737 VAL A 739 -1 O CYS A 738 N MET A 730 CRYST1 92.127 92.533 71.435 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010855 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010807 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013999 0.00000